Radiofrequency Ablation After Left Atrial Appendage Closure in Atrial Fibrillation
Studies radiofrequency ablation one month after appendage closure in adults with atrial fibrillation.
Plain-language title generated from the registry record
Registry title: The Safety and Efficacy of Radiofrequency Ablation After Left Atrial Appendage Occlusion.
Key facts
- Where
- Nantong, ChinaSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 80 years old?
Source: NCT06984731, who can take part
Where in China
- Affiliated Hospital of Nantong UniversityNantong, ChinaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Affiliated Hospital of Nantong University
- Trial code
- NCT06984731
- Record updated
- 22 May 2025
- Original description
Objective: To evaluate the safety and efficacy of transcatheter atrial fibrillation ablation 1 month after WATCHMAN FLX left atrial appendage closure in patients with nonvalvular atrial fibrillation.Read full original descriptionShow less
Clinical Trial Protocol for Safety and Efficacy of Transcatheter Ablation After Left Atrial Appendicular Occlusion With WATCHMAN FLX
Objective: To evaluate the safety and efficacy of transcatheter atrial fibrillation ablation 1 month after WATCHMAN FLX left atrial appendage closure in patients with nonvalvular atrial fibrillation.
Inclusion: ≥18 years of age, diagnosed with nonvalvular atrial fibrillation; Meet the indications for receiving WATCHMAN FLX left atrial appendicular closure and transcatheter atrial fibrillation ablation; Preoperative imaging evaluation showed that the anatomical structure of the left atrial appendage was suitable for implantation with the WATCHMAN FLX device; The patient agrees to participate in the study and signs the informed consent.
Exclusion: left auricular thrombus or acute thrombotic event was found before surgery; valvular heart disease or other structural heart disease that causes atrial fibrillation; Patients with severe bleeding tendency or recent major bleeding events (such as massive gastrointestinal bleeding, cerebral hemorrhage, etc.); Other serious diseases (such as liver and kidney failure, active infection, etc.) were found in preoperative examination; Patients who are unable to complete postoperative follow-up (such as life expectancy of less than 1 year or poor compliance); Pregnant or lactating women.